Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study

Seung Hwan Han,Gyu-Chul Oh,Hyuck Moon Kwon,Chang Gyu Park,In-Jai Kim,Gyo-Seung Hwang,Byung-Su Yoo,Seong Hoon Park,Kwang-Je Lee,Hyo-Soo Kim

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study

2018

Seung Hwan Han
Gyu-Chul Oh
Hyuck Moon Kwon
Chang Gyu Park
In-Jai Kim
Gyo-Seung Hwang
Byung-Su Yoo
Seong Hoon Park
Kwang-Je Lee
Hyo-Soo Kim

Purpose This study aimed to compare the efficacy and safety of generic and branded irbesartan for 8 weeks in patients with mild-to-moderate essential hypertension.

Keywords:

Pharmacology
Irbesartan
Physical therapy
Medicine
open label
Essential hypertension
baseline values
Internal medicine
Intention-to-treat analysis
Diabetes mellitus
Adverse effect
clinical study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations